Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Corteva Inc. (CTVA) Stock Forecast & Price Prediction United States | NYSE | Basic Materials | Agricultural Inputs
$80.34
-0.82 (-1.01%)Did CTVA Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Corteva is one of their latest high-conviction picks.
Based on our analysis of 33 Wall Street analysts, CTVA has a bullish consensus with a median price target of $86.00 (ranging from $74.00 to $96.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $80.34, the median forecast implies a 7.0% upside. This outlook is supported by 15 Buy, 7 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Patrick Cunningham at Citigroup, suggesting a 7.9% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for CTVA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 9, 2026 | UBS | Joshua Spector | Neutral | Maintains | $88.00 |
| Mar 31, 2026 | Argus Research | Bill Selesky | Buy | Maintains | $91.00 |
| Feb 17, 2026 | Mizuho | John Roberts | Outperform | Maintains | $82.00 |
| Feb 5, 2026 | JP Morgan | Jeffrey Zekauskas | Neutral | Downgrade | $77.00 |
| Feb 5, 2026 | Wells Fargo | Michael Sison | Overweight | Maintains | $85.00 |
| Feb 5, 2026 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $89.00 |
| Feb 5, 2026 | Citigroup | Patrick Cunningham | Neutral | Maintains | $80.00 |
| Jan 27, 2026 | Oppenheimer | Kristen Owen | Outperform | Maintains | $78.00 |
| Jan 21, 2026 | JP Morgan | Jeffrey Zekauskas | Overweight | Maintains | $75.00 |
| Jan 21, 2026 | Citigroup | Patrick Cunningham | Neutral | Maintains | $74.00 |
| Jan 16, 2026 | Mizuho | Edlain Rodriguez | Outperform | Maintains | $80.00 |
| Dec 18, 2025 | Citigroup | Patrick Cunningham | Neutral | Maintains | $70.00 |
| Nov 11, 2025 | Wells Fargo | Richard Garchitorena | Overweight | Maintains | $77.00 |
| Oct 30, 2025 | UBS | Joshua Spector | Buy | Maintains | $81.00 |
| Oct 16, 2025 | Wells Fargo | Richard Garchitorena | Overweight | Maintains | $80.00 |
| Oct 13, 2025 | Argus Research | Alexandra Yates | Buy | Maintains | $80.00 |
| Oct 8, 2025 | Mizuho | John Roberts | Outperform | Maintains | $78.00 |
| Oct 6, 2025 | UBS | Joshua Spector | Buy | Maintains | $85.00 |
| Oct 3, 2025 | Keybanc | Aleksey Yefremov | Sector Weight | Downgrade | $N/A |
| Oct 2, 2025 | JP Morgan | Jeffrey Zekauskas | Overweight | Upgrade | $70.00 |
The following stocks are similar to Corteva based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Corteva Inc. has a market capitalization of $54.03B with a P/E ratio of 45.9x. The company generates $17.40B in trailing twelve-month revenue with a 6.3% profit margin.
Revenue growth is -1.7% quarter-over-quarter, while maintaining an operating margin of +5.6% and return on equity of +5.0%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides seed, crop protection, and digital solutions.
Corteva operates through two main segments: Seed and Crop Protection. The Seed segment focuses on developing advanced germplasm and trait technologies to improve crop yields and resilience, while the Crop Protection segment offers various products, including herbicides and fungicides, to combat agricultural challenges. The company's revenue is generated from selling these agricultural products to farmers and stakeholders within the food supply chain.
Corteva emphasizes innovation in seed genetics, crop protection chemistry, and digital agriculture, backed by significant research and development investments. The company plans to spin off into two independent entities in late 2026, allowing for a more focused approach in each segment.
Basic Materials
Agricultural Inputs
21,500
Mr. Charles Victor Magro B.Sc. (Chem), MBA
United States
2019
Here is how Corteva, Inc. (CTVA) and Mama's Creations, Inc. (MAMA) have performed compared to their sector so far this year.
AVO posts double-digit avocado volume growth, but investors watch if pricing pressure and efficiency gains can turn throughput into lasting profits.
Corteva, Inc. (CTVA) and Mama's Creations, Inc. (MAMA) have been evaluated against their sector's performance year-to-date. Specific performance metrics were not provided.
Performance comparisons indicate relative strength or weakness of CTVA and MAMA against their sector, influencing investment decisions based on growth potential and market position.
Corteva Inc. has appointed Luke Kissam as CEO of "New Corteva," a differentiated crop protection company, effective June 1, 2026, ahead of its planned separation in Q4 2026.
The appointment of Luke Kissam as CEO signals a strategic shift for Corteva, emphasizing innovation and efficiency, which could enhance competitiveness and growth potential for investors.
Corteva Inc. (NYSE: CTVA) will separate into a new crop protection company in Q4 2026, led by CEO Luke Kissam, previously of Albemarle.
Corteva's leadership announcement signals strategic direction post-separation, impacting investor confidence and stock performance in the differentiated crop protection sector.
Corteva Inc. (NYSE: CTVA) will create a new company, "SpinCo," specializing in advanced seeds and genetics, set to launch in Q4 2026, led by a new executive team.
Corteva's separation into SpinCo signals a strategic focus on advanced seed and genetics, potentially enhancing shareholder value and attracting investment in ag-tech innovations.
ADM and CTVA are highlighted as leading agriculture stocks, benefiting from innovation, strong pricing, and high product demand amid industry challenges.
ADM and CTVA's strong positioning in agriculture suggests potential resilience and growth, making them attractive options for investors seeking stability amid market challenges.
Corteva, Inc. (CTVA) has reached a 52-week high. Investors are examining the company's fundamentals for potential future growth.
Corteva's 52-week high signals strong performance, but analyzing fundamentals will reveal potential for future growth and investment opportunities.
Based on our analysis of 33 Wall Street analysts, Corteva Inc. (CTVA) has a median price target of $86.00. The highest price target is $96.00 and the lowest is $74.00.
According to current analyst ratings, CTVA has 15 Buy ratings, 7 Hold ratings, and 0 Sell ratings. The stock is currently trading at $80.34. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict CTVA stock could reach $86.00 in the next 12 months. This represents a 7.0% increase from the current price of $80.34. Please note that this is a projection by Wall Street analysts and not a guarantee.
Corteva operates through two main segments: Seed and Crop Protection. The Seed segment focuses on developing advanced germplasm and trait technologies to improve crop yields and resilience, while the Crop Protection segment offers various products, including herbicides and fungicides, to combat agricultural challenges. The company's revenue is generated from selling these agricultural products to farmers and stakeholders within the food supply chain.
The highest price target for CTVA is $96.00 from at , which represents a 19.5% increase from the current price of $80.34.
The lowest price target for CTVA is $74.00 from Patrick Cunningham at Citigroup, which represents a -7.9% decrease from the current price of $80.34.
The overall analyst consensus for CTVA is bullish. Out of 33 Wall Street analysts, 15 rate it as Buy, 7 as Hold, and 0 as Sell, with a median price target of $86.00.
Stock price projections, including those for Corteva Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.